$465 Million is the total value of Samsara BioCapital, LLC's 55 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | CHINOOK THERAPEUTICS INC | $135,241,466 | +33.3% | 5,161,888 | 0.0% | 29.11% | +23.0% | |
| SRRK | SCHOLAR ROCK HLDG CORP | $41,619,393 | +30.6% | 4,598,828 | 0.0% | 8.96% | +20.5% | |
| Sell | ARCELLX INC | $29,661,832 | +48.5% | 957,451 | -10.0% | 6.38% | +37.1% | |
| GRPH | GRAPHITE BIO INC | $28,084,922 | +4.7% | 8,459,314 | 0.0% | 6.04% | -3.3% | |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $18,160,376 | +89.3% | 695,001 | -26.0% | 3.91% | +74.7% |
| RAIN | Buy | RAIN ONCOLOGY INC | $18,085,216 | +137.5% | 2,260,652 | +44.9% | 3.89% | +119.1% |
| ISEE | IVERIC BIO INC | $17,300,158 | +19.3% | 808,041 | 0.0% | 3.72% | +10.1% | |
| NKTX | NKARTA INC | $17,179,530 | -54.5% | 2,868,035 | 0.0% | 3.70% | -58.0% | |
| STRO | SUTRO BIOPHARMA INC | $13,538,678 | +45.6% | 1,675,579 | 0.0% | 2.91% | +34.4% | |
| ZYME | Buy | ZYMEWORKS INC | $12,738,600 | +113.3% | 1,620,687 | +66.9% | 2.74% | +96.8% |
| ACRS | ACLARIS THERAPEUTICS INC | $10,964,693 | +0.1% | 696,171 | 0.0% | 2.36% | -7.6% | |
| HILLEVAX INC | $10,206,337 | -2.1% | 610,062 | 0.0% | 2.20% | -9.6% | ||
| RYTM | RHYTHM PHARMACEUTICALS INC | $10,054,932 | +18.9% | 345,293 | 0.0% | 2.16% | +9.7% | |
| New | PRIME MEDICINE INC | $8,738,248 | – | 470,304 | +100.0% | 1.88% | – | |
| PEPGEN INC | $8,704,539 | +47.2% | 651,050 | 0.0% | 1.87% | +35.8% | ||
| ICPT | INTERCEPT PHARMACEUTICALS IN | $7,925,311 | -11.3% | 640,688 | 0.0% | 1.71% | -18.1% | |
| Sell | DICE THERAPEUTICS INC | $6,326,518 | +23.1% | 202,773 | -20.0% | 1.36% | +13.6% | |
| LYRA | LYRA THERAPEUTICS INC | $5,580,568 | -37.3% | 1,777,251 | 0.0% | 1.20% | -42.1% | |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $5,250,582 | -22.9% | 1,693,736 | 0.0% | 1.13% | -28.8% | |
| JANX | JANUX THERAPEUTICS INC | $4,746,652 | -2.7% | 360,414 | 0.0% | 1.02% | -10.2% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $4,721,368 | +42.9% | 659,409 | 0.0% | 1.02% | +31.9% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $4,620,558 | +21.6% | 80,963 | 0.0% | 0.99% | +12.2% | |
| TANGO THERAPEUTICS INC | $4,567,500 | +100.2% | 630,000 | 0.0% | 0.98% | +84.8% | ||
| IMTX | New | IMMATICS N.V | $4,311,450 | – | 495,000 | +100.0% | 0.93% | – |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $4,227,066 | +7.4% | 196,425 | 0.0% | 0.91% | -0.8% | |
| New | SYROS PHARMACEUTICALS INC | $3,164,406 | – | 881,450 | +100.0% | 0.68% | – | |
| ALXO | ALX ONCOLOGY HLDGS INC | $2,961,598 | +17.8% | 262,786 | 0.0% | 0.64% | +8.7% | |
| IGMS | IGM BIOSCIENCES INC | $2,630,835 | -25.2% | 154,664 | 0.0% | 0.57% | -31.0% | |
| IO BIOTECH INC | $2,319,405 | -15.1% | 1,008,437 | 0.0% | 0.50% | -21.7% | ||
| AMYT | AMRYT PHARMA PLCsponsored ads | $2,224,420 | +5.5% | 304,715 | 0.0% | 0.48% | -2.6% | |
| ALBO | ALBIREO PHARMA INC | $2,161,000 | +11.6% | 100,000 | 0.0% | 0.46% | +3.1% | |
| TERN | Sell | TERNS PHARMACEUTICALS INC | $2,059,903 | +21.0% | 202,348 | -30.0% | 0.44% | +11.6% |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1,680,000 | -55.8% | 480,000 | 0.0% | 0.36% | -59.1% | |
| DBTX | DECIBEL THERAPEUTICS INC | $1,643,339 | -40.8% | 801,629 | 0.0% | 0.35% | -45.3% | |
| ALLK | ALLAKOS INC | $1,448,989 | +37.6% | 172,089 | 0.0% | 0.31% | +26.8% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,363,899 | -12.2% | 1,049,153 | 0.0% | 0.29% | -18.8% | |
| TIL | INSTIL BIO INC | $1,126,616 | -87.0% | 1,788,280 | 0.0% | 0.24% | -88.0% | |
| VTVT | VTV THERAPEUTICS INCcl a | $1,084,015 | -31.7% | 1,635,509 | 0.0% | 0.23% | -37.0% | |
| VIRX | VIRACTA THERAPEUTICS INC | $1,006,975 | -65.8% | 689,709 | 0.0% | 0.22% | -68.4% | |
| ELEV | ELEVATION ONCOLOGY INC | $789,037 | -16.0% | 830,565 | 0.0% | 0.17% | -22.4% | |
| EQ | EQUILLIUM INC | $652,473 | -52.3% | 615,541 | 0.0% | 0.14% | -56.1% | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $577,526 | -8.8% | 22,204 | 0.0% | 0.12% | -16.2% | |
| KALA | Sell | KALA PHARMACEUTICALS INC | $458,716 | +247.5% | 12,024 | -98.0% | 0.10% | +219.4% |
| ALVR | ALLOVIR INC | $422,384 | -35.0% | 82,336 | 0.0% | 0.09% | -40.1% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $397,586 | -14.5% | 883,720 | 0.0% | 0.09% | -20.4% | |
| SCIENCE 37 HOLDINGS INC | $373,680 | -74.2% | 900,000 | 0.0% | 0.08% | -76.3% | ||
| ASTRIA THERAPEUTICS INC | $372,250 | +64.7% | 25,000 | 0.0% | 0.08% | +50.9% | ||
| BCEL | ATRECA INC | $317,706 | -49.0% | 396,835 | 0.0% | 0.07% | -53.1% | |
| NVAX | NOVAVAX INCcall | $240,552 | -43.5% | 23,400 | 0.0% | 0.05% | -47.5% | |
| NVAX | NOVAVAX INC | $218,388 | -43.6% | 21,244 | 0.0% | 0.05% | -47.8% | |
| SURROZEN INC | $174,570 | -71.2% | 300,000 | 0.0% | 0.04% | -73.0% | ||
| KRON | KRONOS BIO INC | $126,572 | -51.7% | 78,131 | 0.0% | 0.03% | -55.7% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $68,618 | -61.7% | 13,669 | 0.0% | 0.02% | -64.3% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $19,267 | -28.6% | 133,333 | 0.0% | 0.00% | -33.3% | |
| SURROZEN INC*w exp 08/01/203 | $5,510 | -69.4% | 99,999 | 0.0% | 0.00% | -75.0% | ||
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -300,000 | -100.0% | -0.70% | – |
| JYAC | Exit | JIYA ACQUISITION CORP | $0 | – | -507,041 | -100.0% | -1.18% | – |
| SYRS | Exit | SYROS PHARMACEUTICALS INC | $0 | – | -881,450 | -100.0% | -1.32% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -1,065,413 | -100.0% | -4.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.